Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04436393 · ClinicalTrials.gov registry record
Guardant360® Related Clinical Outcomes in Patients Who Share Medical Records-Breast Cancer
A clinical trial, sponsored by Guardant Health.
- Completed
- Registry status
- 109
- Enrollment target
NCT04436393 is a clinical trial that has completed, run by Guardant Health. The registered enrollment target is 109 participants.
The verdict
NCT04436393 has completed, sponsored by Guardant Health.
- COMPLETED
- Registry status
- 109 participants
- Enrollment target
Study Summary
The purpose of this study is to observe the routine clinical care of patients who have been diagnosed with breast cancer and have undergone Guardant360 testing.
Interventions
- DIAGNOSTIC_TEST Guardant360 test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 109 participants |
| Start Date | 2020-07-02 |
| Est. Completion | 2022-03-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04436393
The ClinicalTrials.gov registry entry for NCT04436393 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 109 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Guardant Health, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Guardant360 test is the first listed.
NCT04436393 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04436393 about?
NCT04436393 is a clinical study titled "Guardant360® Related Clinical Outcomes in Patients Who Share Medical Records-Breast Cancer". The purpose of this study is to observe the routine clinical care of patients who have been diagnosed with breast cancer and have undergone Guardant360 testing.
What is the current status of trial NCT04436393?
This trial is currently completed. The enrollment target is 109 participants. The study started on 2020-07-02. Estimated completion is 2022-03-17.
What interventions are being tested in trial NCT04436393?
The interventions under investigation include: Guardant360 test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04436393?
This trial is sponsored by Guardant Health, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.